Basit öğe kaydını göster

dc.contributor.authorDanchuk, Oleksii
dc.contributor.authorLevchenko, Anna
dc.contributor.authorMesquita, Rochelly da Silva
dc.contributor.authorDanchuk, Vyacheslav
dc.contributor.authorCengiz, Şeyda
dc.contributor.authorCengiz, Mehmet
dc.contributor.authorGrafov, Andriy
dc.date.accessioned2023-10-03T09:59:07Z
dc.date.available2023-10-03T09:59:07Z
dc.date.issued2023en_US
dc.identifier.citationDanchuk, O.; Levchenko, A.; da Silva Mesquita, R.; Danchuk, V.; Cengiz, S.; Cengiz, M.; Grafov, A. Meeting Contemporary Challenges: Development of Nanomaterials for Veterinary Medicine. Pharmaceutics 2023, 15, 2326. https://doi.org/10.3390/pharmaceutics15092326en_US
dc.identifier.issn1999-4923
dc.identifier.urihttps://doi.org/10.3390/pharmaceutics15092326
dc.identifier.urihttps://hdl.handle.net/20.500.12809/10994
dc.description.abstractIn recent decades, nanotechnology has been rapidly advancing in various fields of human activity, including veterinary medicine. The review presents up-to-date information on recent advancements in nanotechnology in the field and an overview of the types of nanoparticles used in veterinary medicine and animal husbandry, their characteristics, and their areas of application. Currently, a wide range of nanomaterials has been implemented into veterinary practice, including pharmaceuticals, diagnostic devices, feed additives, and vaccines. The application of nanoformulations gave rise to innovative strategies in the treatment of animal diseases. For example, antibiotics delivered on nanoplatforms demonstrated higher efficacy and lower toxicity and dosage requirements when compared to conventional pharmaceuticals, providing a possibility to solve antibiotic resistance issues. Nanoparticle-based drugs showed promising results in the treatment of animal parasitoses and neoplastic diseases. However, the latter area is currently more developed in human medicine. Owing to the size compatibility, nanomaterials have been applied as gene delivery vectors in veterinary gene therapy. Veterinary medicine is at the forefront of the development of innovative nanovaccines inducing both humoral and cellular immune responses. The paper provides a brief overview of current topics in nanomaterial safety, potential risks associated with the use of nanomaterials, and relevant regulatory aspects.en_US
dc.item-language.isoengen_US
dc.publisherMDPIen_US
dc.relation.isversionof10.3390/pharmaceutics15092326en_US
dc.item-rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectNanotechnologyen_US
dc.subjectNanoparticlesen_US
dc.subjectVeterinary medicineen_US
dc.subjectDiagnosticsen_US
dc.titleMeeting Contemporary Challenges: Development of Nanomaterials for Veterinary Medicineen_US
dc.item-typereviewen_US
dc.contributor.departmentMÜ, Milas Veteriner Fakültesi, Klinik Öncesi Bilimler Bölümüen_US
dc.contributor.authorID0000-0002-1273-2941en_US
dc.contributor.institutionauthorCengiz, Şeyda
dc.contributor.institutionauthorCengiz, Mehmet
dc.identifier.volume15en_US
dc.identifier.issue9en_US
dc.identifier.startpage2326en_US
dc.relation.journalPharmaceuticsen_US
dc.relation.publicationcategoryDiğeren_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster